Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D for Sionna Therapeutics, Inc. Common Stock (SION).
- Disclosed ownership: 8.4%.
- Date of event: 10 Feb 2025.
ORBIMED ADVISORS LLC - 10 Feb 2025 SCHEDULE 13D Report for Sionna Therapeutics, Inc. Common Stock (SION)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- SION
- Shares outstanding
- 44,106,655 shares
- Disclosed Ownership
- 3,704,959 shares
- Ownership
- 8.4%
- Form type
- SCHEDULE 13D
- Filing time
- 13 Feb 2025, 16:47:52 UTC
- Date of event
- 10 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 8.4% ownership in Sionna Therapeutics, Inc. Common Stock (SION) on 10 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 16:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 8.4% | 3,704,959 | 0 | 3,704,959 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| OrbiMed Capital GP VIII LLC | 8.4% | 3,704,959 | 0 | 3,704,959 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001845804 |